BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.92−0.01 (-0.91%)
Close on Nov 11, 2026Market cap $13.95MP/E –Yield –
BioCardia operating margin
Operating margin is operating income as a percentage of revenue.
BioCardia's operating margin for the twelve months ending Mar 31, 2025 was -281733.3%. For fiscal 2024 it was -13794.8%, against -2441.1% the year before. The highest annual figure on record is -598.3% in fiscal 2015.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -13794.8% | −11353.7 |
| FY2023 | Dec 31, 2023 | -2441.1% | −1560.8 |
| FY2022 | Dec 31, 2022 | -880.3% | +364.1 |
| FY2021 | Dec 31, 2021 | -1244.3% | +9465.3 |
| FY2020 | Dec 31, 2020 | -10709.7% | −8707.8 |
| FY2019 | Dec 31, 2019 | -2001.8% | +254.5 |
| FY2018 | Dec 31, 2018 | -2256.3% | +333.5 |
| FY2017 | Dec 31, 2017 | -2589.8% | −1268.9 |
| FY2016 | Dec 31, 2016 | -1320.8% | −722.5 |
| FY2015 | Dec 31, 2015 | -598.3% | +4551.7 |
| FY2011 | Dec 31, 2011 | -5150.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -54966.7% | −46938.8 |
| Q1 FY2024 | Mar 31, 2024 | -4136.4% | +1348.0 |
| Q4 FY2023 | Dec 31, 2023 | -16030.8% | −13183.6 |
| Q3 FY2023 | Sep 30, 2023 | -727.7% | +715.7 |
| Q2 FY2023 | Jun 30, 2023 | -8027.9% | −7771.6 |
| Q1 FY2023 | Mar 31, 2023 | -5484.4% | +60.6 |
| Q4 FY2022 | Dec 31, 2022 | -2847.2% | +1533.8 |
| Q3 FY2022 | Sep 30, 2022 | -1443.4% | −1113.6 |
| Q2 FY2022 | Jun 30, 2022 | -256.3% | +4800.3 |
| Q1 FY2022 | Mar 31, 2022 | -5545.0% | +915.9 |
| Q4 FY2021 | Dec 31, 2021 | -4381.0% | +3223.3 |
| Q3 FY2021 | Sep 30, 2021 | -329.8% | +10987.8 |
| Q2 FY2021 | Jun 30, 2021 | -5056.5% | +8180.5 |
| Q1 FY2021 | Mar 31, 2021 | -6460.9% | +5668.1 |
| Q4 FY2020 | Dec 31, 2020 | -7604.3% | −5960.2 |
| Q3 FY2020 | Sep 30, 2020 | -11317.6% | −9654.2 |
| Q2 FY2020 | Jun 30, 2020 | -13237.0% | −8862.6 |
| Q1 FY2020 | Mar 31, 2020 | -12128.9% | −10422.0 |
| Q4 FY2019 | Dec 31, 2019 | -1644.2% | +1909.2 |
| Q3 FY2019 | Sep 30, 2019 | -1663.4% | +2586.6 |
| Q2 FY2019 | Jun 30, 2019 | -4374.4% | −3013.7 |
| Q1 FY2019 | Mar 31, 2019 | -1706.9% | +112.2 |
| Q4 FY2018 | Dec 31, 2018 | -3553.4% | −30.4 |
| Q3 FY2018 | Sep 30, 2018 | -4250.0% | −1912.3 |
| Q2 FY2018 | Jun 30, 2018 | -1360.7% | +1289.3 |
| Q1 FY2018 | Mar 31, 2018 | -1819.1% | +279.4 |
| Q4 FY2017 | Dec 31, 2017 | -3523.0% | −988.7 |
| Q3 FY2017 | Sep 30, 2017 | -2337.7% | −900.1 |
| Q2 FY2017 | Jun 30, 2017 | -2650.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -2098.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -2534.3% | – |
| Q3 FY2016 | Sep 30, 2016 | -1437.6% | – |
See a number that looks wrong?